Provided by Tiger Trade Technology Pte. Ltd.

SIMCERE PHARMA

11.450
-0.400-3.38%
Volume:84.00K
Turnover:962.10K
Market Cap:29.40B
PE:21.20
High:11.800
Open:11.800
Low:11.390
Close:11.850
52wk High:14.081
52wk Low:9.070
Shares:2.57B
HK Float Shares:2.57B
Volume Ratio:1.89
T/O Rate:0.00%
Dividend:0.21
Dividend Rate:1.84%
EPS(LYR):0.540
ROE:18.77%
ROA:7.78%
PB:2.67
PE(LYR):21.20
PS:2.88

Loading ...

Hong Kong Stock Movers: Simcere Pharma (02096) Surges Over 4% in Early Trading as SIM0660's Recent Licensing to Roche Further Validates TCE Platform Value

Stock News
·
Sep 30

Simcere Pharma Releases 2026 Interim Report and Confirms Move to Fully Electronic Investor Communications

Bulletin Express
·
Sep 24

Simcere Pharma Posts 1H26 Revenue of RMB4.58 Billion, Profit Surges 37.9%

Bulletin Express
·
Sep 24

Simcere Pharma Continues Buyback Momentum, Reinforcing Long-Term Shareholder Confidence

Stock News
·
Sep 10

Simcere Pharmaceutical Files HKEX Next-Day Disclosure Return on Share Buyback Cancellation

Reuters
·
Sep 10

Simcere Pharma Buys Back 0.93 Million Shares on 9 Sep; Outstanding Share Count Unchanged at 2.57 Billion

Bulletin Express
·
Sep 09

Simcere Pharma (02096) Allocates HK$10.70 Million to Buy Back 929,000 Shares on September 9

Stock News
·
Sep 09

Simcere Pharmaceutical Files HKEX Next-Day Return Disclosing Share Repurchase for Cancellation

Reuters
·
Sep 09

UBS: Mixed First-Half Results for Chinese Pharma Stocks, Names Simcere as Top Pick

Stock News
·
Sep 09

Simcere Pharmaceutical Announces Approval for Marketing of Yingmule in China by NMPA

Reuters
·
Sep 03

Simcere Says China Approves RSV Prevention Antibody Yingmule for Infants

Reuters
·
Sep 03

Simcere Pharmaceutical - Approval for Marketing of Yingmule in China by National Medical Products Administration

THOMSON REUTERS
·
Sep 03

Simcere Pharma repurchases 1.053 million shares for around HK$12.36 million on September 2

Stock News
·
Sep 02

Simcere Pharma Files HKEX Next-Day Disclosure Return on Share Repurchase for Cancellation

Reuters
·
Sep 02

Simcere Pharmaceutical Jumps Most in Two Months on Roche Tie-up

Reuters
·
Sep 02

Hong Kong stocks open lower | Hang Seng Index dips 0.19% as pharma stocks rally, gold miners slide, SIMCERE PHARMA jumps nearly 5%

Stock News
·
Sep 02

Simcere Zaiming Licenses Sim0660 to Roche in Deal Worth up to $1.53 Billion

Reuters
·
Sep 01

Roche Signs Global Licensing Pact for Simcere's B-Cell Cancer Drug Candidate

Reuters
·
Sep 01

Simcere Clinches US$75.00 Million Upfront, Up to US$1.46 Billion Milestone Deal With Roche for Tri-Specific Antibody SIM0660

Bulletin Express
·
Sep 01

Simcere Pharma Enters Exclusive Global Licensing Pact with Roche for Novel Antibody Asset

Stock News
·
Sep 01